Stereoselective Synthesis of the Indolo[2,3-a]quinolizine Ring System
FULL PAPER
= 3379 (OH), 1640 (NC=O). H NMR (400 MHz, CDCl3): δ
= 1.34–1.40 [m, 1 H, C=CCHCH(H)], 1.64 [s, 9 H, OC(CH3)3],
1.82–1.91 (m, 2 H, CH2CH2C=O), 2.45–2.62 [m, 1 H, CH(H)
1
(m, 2 H, CH2CH2C=O), 2.40–2.48 [m, 1 H, CH(H)CH2CH2C=O],
2.49–2.54 [m, 1 H, CH(H)C=O], 2.69–2.76 [m, 1 H, CH(H)C=O],
3.10 [ddd, J = 16, 8, 4 Hz, 1 H, CH(H)CHCHO], 3.41–3.47 [m, 1
ν
˜
max
H, CH(H)CHCHO], 4.89–4.93 (m, 1 H, C=CCH), 5.97–5.99 (m, 1 C=O], 2.45–2.62 [m, 1 H, C=CCHCH(H)], 2.45–2.62 [m, 1 H,
H, CHCHO), 7.11–7.24 (m, 2 H, ArH), 7.30–7.32 (m, 1 H, ArH), CH(H)C=O], 2.83–2.89 [m, 1 H, C=CCH(H)], 3.35–3.41 [m, 1 H,
7.53–7.55 (m, 1 H, ArH), 8.15 (br. s, 1 H, NH), 9.49 (s, 1 H, CHO) C=CCH(H)], 5.33–5.36 (m, 1 H, C=CCH), 5.98–6.0 (m, 1 H,
ppm. 13C NMR (100 MHz, CDCl3): δ = 19.5 (CH2), 20.0 (CH2), NCHCO2H), 7.18–7.28 (m, 2 H, ArH), 7.39–7.41 (m, 1 H, ArH),
29.6 (CH2), 32.0 (CH2), 52.2 (CH), 56.8 (CH), 106.4 (C), 111.1
(CH), 118.3 (CH), 120.0 (CH), 122.6 (CH), 126.5 (C), 132.7 (C), NMR (100 MHz, CDCl3): δ = 19.0 (CH2), 23.2 (CH2), 28.2
8.03 (d, J = 8 Hz, 1 H, ArH), 8.80 (br. s, 1 H, CO2H) ppm. 13C
136.5 (C), 170.4 (NC=O), 199.3 (CHO) ppm. MS (EI): m/z (%)
= 268 (75.9) [M+], (found: M+, 268.12130. C16H16N2O2 requires
268.12118).
(3×CH3), 30.4 (CH2), 31.3 (CH2), 49.8 (CH), 54.1 (CH), 84.4 (C),
115.0 (C), 115.7 (CH), 118.4 (CH), 123.0 (CH), 124.8 (CH), 128.4
(C), 133.9 (C), 136.8 (C), 149.9 [NC(O)OtBu], 172.1 (NC=O), 173.0
[C(O)OH] ppm. MS (EI): m/z (%) = 384 (2) [M+] (found: M+,
384.16768. C21H24N2O5 requires 384.16852).
(6R,12bS)-tert-Butyl-6-formyl-1,2,3,4,6,7-hexahydro-4-oxoindolo-
[2, 3-a]quinolizine-12(12bH)-carboxylate: (6R,12bS)-
1,2,3,4,6,7,12,12b-octahydro-4-oxoindolo[2,3-a]quinolizine-6-carb-
aldehyde (3.5 g, 13.1 mmol) was dissolved in anhydrous tetra-
hydrofuran (40.0 mL) under nitrogen. Triethylamine (3.7 mL,
26.2 mmol). 4-(Dimethylamino)pyridine (0.35 g, 2.7 mmol) and di-
tert-butyl dicarbonate (3.8 g, 17.1 mmol) were added successively,
and the resulting solution was stirred at room temperature under
nitrogen for 4 hours. After this time the volatiles were removed by
rotary evaporation and the resulting residue was re-dissolved in
ethyl acetate (200 mL) and washed successively with saturated
aqueous ammonium chloride (2×200 mL), saturated aqueous so-
dium hydrogencarbonate (2×200 mL) and brine (200 mL). The or-
ganic layer was dried with anhydrous magnesium sulfate, the sol-
vent removed under rotary evaporation and the crude product was
adsorbed onto silica and purified by flash column chromatography
over silica using ethyl acetate/hexane (3:2) as eluent. The product
was isolated as a yellow oil (2.6 g, 63%). [α]D = –925.3 (c = 3.0,
Radical-Induced Decarboxylation Strategy
(6R,12bS)-tert-Butyl-1,2,3,4,6,7-hexahydro-4-oxo-6-[(phenylselan-
yl)carbonyl]indolo[2,3-a]quinolizine-12(12bH)-carboxylate: To a
flask containing compound 8 (1.9 g, 4.95 mmol) under nitrogen
was added anhydrous dichloromethane (30.0 mL) followed by di-
phenyl diselenide (2.4 g, 7.5 mmol). The resulting mixture was co-
oled to 0 °C and tributylphosphane (90 % grade) (3.1 mL,
10.1 mmol) was added dropwise. The solution was warmed to room
temperature and stirring continued for a further 18 hours at room
temperature. Dichloromethane (100 mL) and water (100 mL) were
added and the aqueous layer was extracted with a further (100 mL)
of dichloromethane. The combined organic fractions were washed
with brine (100 mL), dried with anhydrous magnesium sulfate and
the solvents evaporated to dryness to give the crude product which
was purified by flash column chromatography over silica eluting
with hexane/ethyl acetate (8:2), then ethyl acetate/hexane (3:2) giv-
ing the title compound as a pale yellow foam (1.72 g, 66%), m.p.
75–77 °C. [α]D = –84 (c = 1.0, CH2Cl2). IR (thin film, DCM, cm–1):
CH Cl ). IR (thin film, DCM, cm–1): ν
= 1729 (CHO), 1653
˜
max
2
2
(NBoc[C=O]). 1H NMR (400 MHz, CDCl3): δ = 1.41–1.50 [m, 1
H, C=CCHCH(H)], 1.67 [s, 9 H, OC(CH3)3], 1.96–2.04 (m, 2 H,
CH2CH2C=O), 2.50–2.59 [m, 1 H, CH(H)C=O], 2.61–2.65 [m, 1
H, C=CCHCH(H)], 2.71–2.78 [m, 1 H, CH(H)C=O], 2.96 [ddd, J
= 16, 8, 4 Hz, 1 H, C=CCH(H)], 3.35–3.40 [m, 1 H, C=CCH(H)],
5.26–5.29 (m, 1 H, C=CCH), 5.92–5.94 (m, 1 H, NCHCHO), 7.24–
7.34 (m, 2 H, ArH), 7.47–7.49 (m, 1 H, ArH), 8.04–8.06 (m, 1 H,
ArH), 9.52 (s, 1 H, CHO) ppm. 13C NMR (100 MHz, CDCl3): δ =
19.3 (CH2), 20.5 (CH2), 28.4 (3×CH3), 30.6 (CH2), 31.7 (CH2), 54.0
(CH), 56.1 (CH), 84.6 (C), 114.7 (C), 115.7 (CH), 118.2 (CH), 123.1
(CH), 125.0 (CH), 128.1 (C), 134.5 (C), 136.9 (C), 149.8 [NC(O)
OtBu], 170.9 (NC=O), 199.1 (CHO) ppm. MS (EI): m/z (%) = 368
(54.1) [M+] (found: M+, 368.17367. C21H24N2O4 requires
368.17361).
ν
˜
= 1729 (COSePh), 1654 (NC=O). 1H NMR (400 MHz,
max
CDCl3): δ = 1.44–1.54 [m, 1 H, C=CCHCH(H)], 1.70 [s, 9 H,
OC(CH3)3], 1.95–2.11 (m, 2 H, CH2CH2C=O), 2.60–2.68 [m, 1 H,
C=CCHCH(H)], 2.60–2.68 [m, 1 H, CH(H)C=O], 2.78–2.85 [m, 1
H, CH(H)C=O], 2.87–2.93 [m, 1 H, C=CCH(H)], 3.47–3.52 [m, 1
H, C=CCH(H)], 5.56–5.59 (m, 1 H, NCHCOSePh), 6.15–6.17 (m,
1 H, ArH), 7.24–7.32 (m, 5 H, ArH), 7.39–7.40 (m, 2 H, ArH),
7.43–7.46 (m, 1 H, ArH), 8.03–8.06 (m, 1 H, ArH) ppm. 13C NMR
(100 MHz, CDCl3): δ = 19.0 (CH2), 22.4 (CH2), 28.3 (3×CH3),
31.1 (CH2), 31.8 (CH2), 54.1 (CH), 59.6 (CH), 84.5 (C), 114.8 (C),
115.7 (CH), 118.4 (CH), 123.1 (CH), 124.9 (CH), 125.4 (C), 128.3
(C), 128.9 (CH), 129.2 (2×CH), 133.5 (C), 136.0 (2×CH), 136.8
(C), 149.9 [NC(O)OtBu], 171.6 (NC=O), 200.3 (COSePh) ppm. MS
(CI): m/z (%) = 525 (6.7) [MH+] (found: MH+, 525.13013.
C27H29N2O4Se requires 525.12925).
(6R,12bS)-12-(tert-Butoxycarbonyl)-1,2,3,4,6,7,12,12b-octahydro-4-
oxoindolo[2,3-a]quinolizine-6-carboxylic Acid (8): A solution of
(6R,12bS)-tert-butyl-6-formyl-1,2,3,4,6,7-hexahydro-4-oxoindolo-
[2,3-a]quinolizine-12(12bH)-carboxylate (2.6 g, 7.1 mmol) in aceto-
nitrile (35.0 mL), tert-butyl alcohol (130.0 mL) and 1-methyl-1-cy-
clohexene (63.0 mL) was stirred rapidly as it was cooled to 0 °C. A
solution of sodium chlorite (80% grade) (6.3 g, 54.7 mmol) and
(12bS)-tert-Butyl-1,2,3,4,6,7-hexahydro-4-oxoindolo[2,3-a]quinol-
izine-12(12bH)-carboxylate (9): A three-necked flask fitted with a
condenser, glass stopper and a suba seal was flushed with nitrogen.
A solution of (6R,12bS)-tert-butyl1,2,3,4,6,7-hexahydro-4-oxo-6-
sodium dihydrogen phosphate (6.3 g, 49.7 mmol) in water [(phenylselanyl)carbonyl]indolo[2,3-a]quinolizine-12(12bH)-carb-
(130.0 mL) was added dropwise over a period of 10 minutes at 0 °C.
The solution was then stirred at room temperature for a further
18 hours. After this time the reaction was partitioned between ethyl
acetate (300 mL) and brine (200 mL). The ethyl acetate layer was
oxylate (1.7 g, 3.2 mmol) in anhydrous toluene (20.0 mL) was
added through a cannula. The solution was then degassed with
nitrogen for 15 minutes before adding tri-n-butyltin hydride
(3.5 mL, 13.2 mmol) via syringe. The resulting mixture was heated
then washed with 1 aqueous sodium dithionite solution to 80 °C in an oil bath whereupon azobis(isobutyronitrile) (0.1 g,
(100 mL). The organic layer was dried with anhydrous magnesium
sulfate and the solvents evaporated to dryness to give the target
compound which was purified by flash column chromatography
over silica eluting with ethyl acetate yielding a yellow oil (1.9 g,
0.6 mmol) was added portionwise over a 2 hour period at 80 °C.
After 2 hours stirring at 80 °C the mixture was cooled to room
temperature and the solvent removed on the rotary evaporator. The
resulting crude oil was adsorbed onto silica and purified by flash
70%). [α]D = –530 (c = 1.0, CH2Cl2). IR (thin film, DCM, cm–1): column chromatography over silica eluting with hexane followed
Eur. J. Org. Chem. 2005, 4179–4186
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
4183